Exevir Press Release
2023-03-13

ExeVir Bio and VIB Announce Data on a New Therapy for Prevention and Treatment for COVID-19.

ExeVir Bio and VIB-UGent’s bioRxiv…
read more
Exevir Press Release
2023-01-09

Belgium: ExeVir lands European venture debt financing to develop novel nanobody COVID-19 therapy

ExeVir signs €25 million venture debt…
read more
Exevir Press Release
2022-10-20

ExeVir Bio Forges Ahead with Unique Next Generation COVID-19 Therapy and Appoints Dr. Jeanne Bolger as Chair of the Board of Directors

Targeting final lead therapy selection,…
read more
Exevir Press Release
2021-09-01

ExeVir Announces First Patient Enrolled in Phase 1b/2 Clinical Study evaluating XVR011 as antiviral treatment of patients hospitalised for COVID-19

ExeVir Announces First Patient Enrolled…
read more
Exevir Press Release
2021-08-18

ExeVir announces first subjects dosed in Phase I clinical study of potent COVID-19 neutralizing antibody

ExeVir announces first subjects dosed…
read more
Exevir Press Release
2021-07-15

ExeVir and Mithra announce manufacturing collaboration for innovative Covid-19 treatments

ExeVir and Mithra announce manufacturing…
read more
Exevir Press Release
2021-07-13

ExeVir’s COVID-19 antibody candidate neutralizes coronavirus Variants of Concern

ExeVir’s COVID-19 antibody candidate neutralizes…
read more
Exevir Press Release
2021-03-16

ExeVir Announces Close of US$50 million / EUR42 million Series A Financing

ExeVir Announces Close of US$50…
read more
Exevir Press Release
2021-03-09

ExeVir Bio Announces New Publication from VIB Scientists Showing Potent and Broad Neutralizing Activity and Infection Protection Against SARS-COV, its Variants of Concern and Related Coronaviruses

ExeVir Bio Announces New Publication…
read more
Exevir Press Release
2020-11-03

ExeVir Bio Appoints Michel Kazatchkine and Stef Heylen to the Board of Directors

ExeVir Bio Appoints Michel Kazatchkine…
read more